ArticleVeterinary world2025
Phytobiotic-enriched multiphase feeding improves growth and reproductive performance in Manchurian quails: Evidence from controlled farm trials in Kazakhstan.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Manchurian quails are valued in commercial poultry farming for their early meat maturity, rapid generational turnover, and high egg-laying potential. However, concerns over antibiotic use in feed have heightened interest in sustainable alternatives such as phytobiotics. Despite evidence supporting phytogenic feed additives, limited studies have examined their effects in Manchurian quails under multiphase feeding regimens. This study evaluated the effects of phytobiotic-enriched, extruded feeds (BioFeed-P) across three feeding phases ("Starter," "Grower," and "Layer") on growth performance, egg productivity, and product quality in Manchurian quails. Materials and Methods: A total of 1600 1-day-old quails were randomly allocated into experimental group (EG) and control group (CG) at two commercial farms (JEBE; Zhailybayev Experimental Breeding Enterprise and ECO-KO; Ecological Cooperative Kazakhstan Organization)in Kazakhstan. EG received phytobiotic-enriched multiphase feeds, whereas CG was provided standard commercial diets. Growth rate, feed conversion ratio (FCR), survivability, and egg production were measured over a 90-day period. Product quality was assessed by analyzing egg morphology, chemical composition, and mineral profiles. Statistical analyses included the Student's t-test, correlation analysis, and determination of effect size. Results: Quails in EG showed significantly higher body weight gain (186.3 g vs. 135.3 g; relative gain 415.5% vs. 297.5%; p = 0.003, Cohen's d = 1.12) and improved FCR (2.05 vs. 2.45; p = 0.001). Egg-laying intensity was greater in EG at both ECO-KO (64.4% vs. 41.3%; p = 0.004) and JEBE (69.0% vs. 40.0%; p = 0.003). Egg morphology showed modest changes: Heavier albumen, reduced shell weight, and lighter yolk pigmentation. Chemical analyses revealed slight decreases in protein and fat fractions accompanied by minor increases in carbohydrate and ash content, while the mineral composition remained stable. Mortality was lower in EG (3.8% vs. 7.7%), with no adverse health effects. Conclusion: Phytobiotic-enriched multiphase feeds significantly enhance growth efficiency and reproductive output in Manchurian quails without compromising mineral egg quality. These findings support phytobiotics as sustainable alternatives to antibiotics in commercial quail farming. Future research should include long-term reproductive assessments, economic cost-benefit analyses, and molecular studies to elucidate the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.